Back to Treatments

Treatment

Rivastigmine

2
Conditions
58
Trials
24K
Participants
59%
Average Safety

Condition Evidence

Alzheimer's Disease

55 trials · 20K participants

43% effectiveness · 58% safety

Lewy Body Dementia

3 trials · 4,200 participants

70% effectiveness · 60% safety
Rivastigmine | DFDA